SFA Therapeutics to Present Human Psoriasis Data for Microbiome-based Drug (SFA002) at the Global Biotech Entrepreneur Forum and the BIO International Convention
PHILADELPHIA--(BUSINESS WIRE)--May 31, 2019--
PHILADELPHIA--(BUSINESS WIRE)--May 31, 2019--